Trial · NCT04259112
Effect of Pneumoperitoneum and Neuromuscular Block on Renal Function in Diabetes Patients
NCT04259112, Not applicable, Unknown, Peking Union Medical College Hospital
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Effect of Pneumoperitoneum and Neuromuscular Block on Renal Function in Diabetes Patients. Trials, record NCT04259112. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT04259112
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Effect of Pneumoperitoneum and Neuromuscular Block on Renal Function in Diabetes Patients
- NCT number
- NCT04259112
- Status
- Unknown
- Phases
- Not applicable
- Enrollment
- 648 participants, estimated
- Lead sponsor
- Peking Union Medical College Hospital
- Conditions
- Diabetes Mellitus, Acute Kidney Injury, Laparoscopic Surgical Procedure, Neuromuscular Blockade
- Interventions
- high pressure, deep neuromuscular block, low pressure, moderate neuromuscular block
- First posted
- 2020-02-06
- Last updated
- 2020-10-06
Source ClinicalTrials.gov
Registered outcomes12
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Serum cystatin C (CysC) level | 30 minutes before pneumoperitoneum insufflation | CysC is a sensitive indicator for early kidney injury, and can be used to estimate glomerular filtration rate (GFR). |
| Primary | Serum cystatin C (CysC) level | 30 minutes after pneumoperitoneum deflatation | CysC is a sensitive indicator for early kidney injury, and can be used to estimate glomerular filtration rate (GFR). |
| Primary | Serum cystatin C (CysC) level | Postoperative 24 hours | CysC is a sensitive indicator for early kidney injury, and can be used to estimate glomerular filtration rate (GFR). |
| Secondary | Serum creatine level | 30 minutes before pneumoperitoneum insufflation | Creatine is also an indicator for kidney injury |
| Secondary | Serum creatine level | 30 minutes after pneumoperitoneum deflatation | Creatine is also an indicator for kidney injury |
| Secondary | Serum creatine level | Postoperative 24 hours | Creatine is also an indicator for kidney injury |
| Secondary | The volume of intraoperative urine output | At the end of the surgery | A urine tube will be inserted just before the surgery, so the urine can be drained into a bag. The volume of urine in the bag at the end of the surgery will be the volume of intraoperative urine output. |
| Secondary | The presence of isomorphic or dysmorphic erythrocyte in urinary sediment | Postoperative day 1 | Erythrocyte in urinary sediment is also an indicator of renal injury. |
| Secondary | Duration of surgery | Intraoperative | Duration of surgery is an indicator for procedure difficulty |
| Secondary | Leiden-surgical rating scale | The moment when trocars are introduced into pelvic cavity, and then every 15 minutes till the end of surgery. | We will use Leiden surgical rating scale (Martini et al.) to assess surgical condition. It is a 5-point scale, the minimum and maximum values are 1 and 5, respectively. Higher score indicates better surgical condition. |
1 to 10 of 12Source ClinicalTrials.gov
See all 12 registered outcomesOutcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers1
The papers the trial lists on ClinicalTrials.gov.
| PMID | Listed as |
|---|---|
| 32600358 | DERIVED |
Source PubMed
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT04259112
GET https://conductscience.org/api/trials/v1/NCT04259112/registered